Pridružen/a: 24. 01. 2018.
|Postano: uto ožu 06, 2018 12:29 pm Naslov: Require help with technicalities of Ashenden article
I tend to immerse myself in clinic reading whenever a particular issue (Contador positive, Landis/Hamilton accusations, UK Postal) piques my interest. Consequently my knowledge is functional rather than comprehensive and am seeking clarification on several issues. Questions:
Ashenden addresses the problem with attempting to maintain haemoglobin levels via simultaneously transfusing red blood cells and plasma. Could this not be remedied through the use of an exchange transfusion? It is stated that with correct timing and titration epo can be utilised as a masking agent for blood infusion by normalising reticulocyte levels. Out of competition testing necessitates a corresponding protocol for concealing blood withdrawl. Is this acheived through a post-withdrawl suspension of the micro-dosing of epo? Regarding the adverse analytical finding of clenbuterol in Contador's blood sample; are we to deduce a flaw in the screening processs (inability to detect a concentration of 50 picograms)?
I did not find the right solution from the internet.
Online video production company